Compare IONQ & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IONQ | MEDP |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 13.4B |
| IPO Year | N/A | 2016 |
| Metric | IONQ | MEDP |
|---|---|---|
| Price | $46.83 | $561.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 12 |
| Target Price | $68.57 | ★ $468.82 |
| AVG Volume (30 Days) | ★ 19.7M | 271.2K |
| Earning Date | 11-05-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.36 |
| EPS | N/A | ★ 14.32 |
| Revenue | $79,836,000.00 | ★ $2,358,373,000.00 |
| Revenue This Year | $148.30 | $21.48 |
| Revenue Next Year | $78.94 | $11.90 |
| P/E Ratio | ★ N/A | $38.90 |
| Revenue Growth | ★ 113.07 | 13.88 |
| 52 Week Low | $17.88 | $250.05 |
| 52 Week High | $84.64 | $626.26 |
| Indicator | IONQ | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 48.06 |
| Support Level | $45.92 | $544.24 |
| Resistance Level | $52.15 | $569.00 |
| Average True Range (ATR) | 3.77 | 14.92 |
| MACD | -0.06 | -1.60 |
| Stochastic Oscillator | 14.22 | 52.23 |
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.